Throughout history, science has been our tool for unravelling the complexities of life and improving medical treatments, including how cells interact, chemical reactions unfold, and drugs bind to their targets. In recent years, artificial intelligence (AI) has taken this to a new level. By collecting and processing vast amounts of data, AI is helping us identify new therapeutic targets and create treatments on an entirely different scale.
Upon first glance, Altery might look unassuming: as a company operating in the fintech sector, it offers secure cross-border payments and multi-currency wallets for its customers around the world. But scratch the surface, and you’ll find a company that is looking to disrupt fintech and traditional banking more generally, as I learned from speaking to Bisi Giwa, Managing Director of Altery.

















